Osteosarcoma of the jaw - experience at the Medical University Vienna and comparative study with international tumor registries

OBJECTIVES: Osteosarcoma of the jaw (OSAJ) is fundamentally different in clinical practice from its peripheral counterparts. Studies are difficult to conduct due to low incidence rates. The primary aim of this study was to provide for the first time a comprehensive retrospective analysis of the treatment concepts and outcome data of OSAJ patients treated at the University Hospital Vienna and to compare these with two recently published studies on OSAJ. The clinical study was accompanied by a biomarker study investigating the prognostic relevance of melanoma-associated antigen-A (MAGE-A) in OSAJ specimens. METHOD: Eighteen patients were included, and their outcomes were compared to published data. Immunohistochemistry was performed with mouse monoclonal antibodies against MAGE-A. Survival rates were estimated by the Kaplan-Meyer method. The log-rank test was used to analyze potential prognostic parameters. Fisher's exact test was performed to define the significant differences between the survival rates of the current study and the DOESAK registry. RESULTS: Disease-specific survival was 93.8% after five and 56.3% after ten years. The development of metastases (p=0.033) or relapse (p=0.037) was associated with worsened outcomes in our group as well as in the comparative group. Despite the different treatment concepts of the study groups, survival rates were comparable. MAGE-A failed to show prognostic relevance for OSAJ patients. CONCLUSIONS: Uncertainties about the optimal treatment strategies of OSAJ patients will currently remain. Thus, prospective studies of OSAJ are needed but are only feasible in a multicenter study setting, conducted over a prolonged time period.

Difference of Toxoplasma gondii antibodies between Thai and Austrian pregnant women.

Toxoplasma gondii IgG and IgM antibodies of Thai and Austrian pregnant women were studied, in the same laboratory unit, by using the Sabin-Feldman dye test and ISAGA-IgM. In Thai pregnant women, IgG antibody was found in 21.7%, mostly the IgG titers were low and all were negative for IgM antibody. Conversely in Austrian pregnant women, IgG antibody was found in 30.0% with high titer, and there were 19 (6.3%) cases positive for IgM antibody. The seropositivity of T. gondii IgG antibody in Austrian pregnant women was significantly higher than in Thai (p = 0.02) and the titers were much higher. Two possibilities are postulated to explain the data: it may be because Thai women were infected at a younger age than Austrian women, so they were in the chronic infection stage corresponding with their negativity of IgM antibody or it may be due to the difference of strain virulence of T. gondii from the different parts of the world.